Search Orphan Drug Designations and Approvals
-
Generic Name: | Botulinum toxin type A | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Name: | Dysport | ||||||||||||||||
Date Designated: | 10/20/1999 | ||||||||||||||||
Orphan Designation: | Treatment of dynamic muscle contractures in pediatric cerebral palsy patients. | ||||||||||||||||
Orphan Designation Status: | Designated/Approved | ||||||||||||||||
Sponsor: |
Ipsen Biopharmaceuticals, Inc. 650 East Kendall Street Cambridge, Massachusetts 02142 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
||||||||||||||||
Marketing approved: |
|||||||||||||||||
1 | Generic Name: | Botulinum toxin type A |
---|---|---|
Trade Name: | Dysport | |
Marketing Approval Date: | 07/29/2016 | |
Approved Labeled Indication: | Treatment of lower limb spasticity in pediatric patients 2 years of age and older | |
Exclusivity End Date: | 07/29/2023 | |
Exclusivity Protected Indication* : | Treatment of lower limb spasticity in pediatric cerebral palsy patients 2 years of age and older | |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-